Back | Next |
home / stock / mist / mist message board
Subject | By | Source | When |
---|---|---|---|
Looking like this ran out of steam. Honestly, | swingingRichard | investorshub | 05/05/2020 1:24:24 AM |
* * $MIST Video Chart 05-01-2020 * * | ClayTrader | investorshub | 05/01/2020 9:59:20 PM |
New high of the day would be awesome. | fitzkarz | investorshub | 05/01/2020 7:41:54 PM |
nice... you have a cushion | TheFinalCD | investorshub | 05/01/2020 7:11:39 PM |
Bottom keeps moving up. Been avg up, since $1.95. | fitzkarz | investorshub | 05/01/2020 6:58:38 PM |
traded the entire Outstanding shares today | TheFinalCD | investorshub | 05/01/2020 6:53:33 PM |
hold. | aristotelisonassis | investorshub | 05/01/2020 6:29:34 PM |
Maybe. I would not be too surprised. | swingingRichard | investorshub | 05/01/2020 6:25:30 PM |
$IMO $MIST should be, And will be between | fitzkarz | investorshub | 05/01/2020 6:07:21 PM |
as predicted. Made 73%. Taking the money and running. | swingingRichard | investorshub | 05/01/2020 4:16:02 PM |
She's thin folks | megabandp | investorshub | 05/01/2020 1:57:15 PM |
Yes sir, Slow and steady. Loving me some $MIST | fitzkarz | investorshub | 05/01/2020 2:03:37 AM |
strong buy and volume alert! $3 | aristotelisonassis | investorshub | 04/30/2020 8:03:28 PM |
Thanks, Will see. I'm all in $MIST! | fitzkarz | investorshub | 04/22/2020 7:23:37 PM |
investorshub.advfn.com/uimage/uploads/2020/4/22/hiirbMIST.jpg | swingingRichard | investorshub | 04/22/2020 3:13:44 PM |
Only if they report a successful P2 trial | QServus | investorshub | 04/21/2020 12:56:06 PM |
With 71.91% held by institutions. | fitzkarz | investorshub | 04/14/2020 9:34:54 PM |
up 12.97% today | edwardport | investorshub | 04/13/2020 11:17:57 PM |
could be more upside yet | edwardport | investorshub | 04/13/2020 12:07:12 AM |
Im in | GotDrys | investorshub | 04/09/2020 3:48:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Milestone Pharmaceuticals Inc. Company Name:
MIST Stock Symbol:
NYSE Market:
– NDA for etripamil in PSVT resubmitted in 1Q 2024 – Cash resources as of March 31, 2024 expected to fund operations into 2026 – Dialogue with FDA to finalize Phase 3 protocol for etripamil in AFib-RVR is progressing MONTREAL and ...
MONTREAL and CHARLOTTE, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced upcoming data presentations on etripam...
MONTREAL and CHARLOTTE, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company...